The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.
about
Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsCombination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal functionLong-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionRenal angiotensin-converting enzyme and blood pressure controlRediscovering ACE: novel insights into the many roles of the angiotensin-converting enzymeThe intrarenal generation of angiotensin II is required for experimental hypertensionHeparin binds lamprey angiotensinogen and promotes thrombin inhibition through a template mechanismAngiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondInteraction of the renin angiotensin and cox systems in the kidney.Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis.Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs.Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.Renoprotective effect of Linum usitatissimum seeds through haemodynamic changes and conservation of antioxidant enzymes in renal ischaemia-reperfusion injury in ratsAliskiren and valsartan combination therapy for the management of hypertension.Angiotensin converting enzyme activity in alopecia areataRenal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition.Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndromeThe influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartanIntrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusionRole of mineralocorticoid receptor antagonists in cardiovascular disease.Reappraisal of role of angiotensin receptor blockers in cardiovascular protectionPerindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptorValsartan combination therapy in the management of hypertension - patient perspectives and clinical utilityDevelopment of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD.New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil.Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathwaysAldosterone induces clonal β-cell failure through glucocorticoid receptor.Gastrointestinal Endogenous Protein-Derived Bioactive Peptides: An in Vitro Study of Their Gut Modulatory Potential.Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused ratsFunctional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells.Inhibition of renin activity slows down the progression of HIV-associated nephropathyA systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease.Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathyDung-Shen Downregulates the Synergistic Apoptotic Effects of Angiotensin II Plus Leu 27-IGF II on Cardiomyoblasts.The absence of intrarenal ACE protects against hypertensionExpression of renin-angiotensin system components in the early bovine embryo
P2860
Q26764927-49E1E8D0-36BA-48F8-8B2E-AB863AB3437FQ26795398-7A025027-491D-41B2-9EB4-75247E328FEEQ26824261-6EC5D139-7192-4C09-AF1F-70FDA78F8892Q26827777-4C795C51-40D2-4556-AB65-35B82CDFEC74Q27004277-D1202198-791A-4E0B-8A3D-8A07ED31775DQ27025017-3CA52BBD-4FA4-4E29-83EC-8F7DBD5CA972Q27728134-80CC424A-7389-4B34-A4F2-868AB56BE509Q28088583-AB7FF17A-47E7-451B-9AF7-9C47DC0F8B73Q30276943-1FD261DB-8FCD-4274-9BAA-6271F324E724Q30429844-79E2C542-9248-4ABA-AC07-D9523823A469Q30491698-D0D8B57A-C09E-4502-9356-0AEC2FF1F72EQ33567144-23B98166-7B7B-4EF0-B6C1-21A933A4F71CQ33756874-D3AA4FAD-9FDC-4E34-BE9A-3F1EAD9464A7Q33783689-84CFF065-CFF3-4D63-A16D-7CC810CD1C95Q33788229-52457FA3-5AFB-44CD-B7F7-B9F435381D34Q33875341-B4E0649C-5935-4547-A8EE-C10D95A58F31Q34114780-59B6EC5F-BE1D-4D00-A0FF-C0F2CA39C7E2Q34139070-EFBA30B6-B01D-487F-9E39-80DC8C71E11DQ34347166-EDA51134-C26A-4D37-BFB2-E6121580028CQ34568769-1570C77E-0341-47B4-8B4E-F5DB79CE1B1EQ34630458-E29A88F7-511F-4E49-AB62-C60CD0C85FBBQ34677197-13316189-9E19-4185-A777-606DD4497087Q34695342-01002316-8477-400E-86F2-18719F4B0966Q34817129-980DD465-1565-4881-82EE-2023B90F989CQ35015215-D64823D6-72A3-479A-BC7C-24C8FADC97F3Q35029497-43566DDF-81A6-4473-8D6E-B632EFDC713BQ35210583-6875EF3D-D965-40F4-9B3C-A2A399C2A297Q35612465-5174B758-FDB2-4CC5-9C2E-2516FCA556F0Q35841718-2E25E520-F11A-4987-BE5D-C40B1C1C0890Q35875449-C1B09E5B-DB5D-4E6F-98FA-B09C4694F1F0Q35969504-9B64E625-E81A-40BB-B53A-955DDB26F7F1Q35979232-AD75B026-48E7-4352-8C34-C3423BB3410BQ36132755-5421DDB6-C876-4BA3-A79A-C49F691390CEQ36309350-9DEE4A80-2F39-45E7-B805-A8AB768A47E0Q36309378-B55C1177-081A-49E9-83C3-9FAA1FAA982DQ36396593-DF4BBDDF-F94E-4E77-BCF0-226E1BF90304Q36605186-5CB26697-2E4F-4B1A-85B5-5EEC3C040ED0Q36721287-F0E1935F-5B3D-424D-8C17-CA0AA7FAFACEQ36802752-FDBADC7A-124B-41DA-8208-34C721A09622Q36925629-D46B339D-4049-47ED-ABFA-D8C57F348E5B
P2860
The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@ast
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@en
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@nl
type
label
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@ast
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@en
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@nl
prefLabel
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@ast
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@en
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@nl
P1476
The renin-angiotensin aldoster ...... and pharmacologic inhibition.
@en
P2093
Steven A Atlas
P356
10.18553/JMCP.2007.13.S8-B.9
P433
P577
2007-10-01T00:00:00Z